|
|
|
Volumn 28, Issue 4, 1996, Pages 2234-2236
|
|
Interim analysis of study OLN-356: Neoral versus sandimmune in US primary liver transplant recipients
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN A;
ADULT;
AGED;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG FORMULATION;
FEMALE;
GRAFT REJECTION;
HUMAN;
HYPERTENSION;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NEPHROTOXICITY;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT FAILURE;
ADMINISTRATION, ORAL;
ADULT;
CHI-SQUARE DISTRIBUTION;
CYCLOSPORINE;
DOSAGE FORMS;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
UNITED STATES;
|
|
EID: 0029835514
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (0)
|
